Published in Biochemistry on April 17, 1979
Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest (1983) 2.39
Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin. Biochem J (1981) 1.78
Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol (1980) 1.48
The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan. Biochem J (1981) 1.40
Molecular weight of the membrane C5b-9 complex of human complement: characterization of the terminal complex as a C5b-9 monomer. Proc Natl Acad Sci U S A (1981) 1.15
Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments. J Exp Med (1983) 1.13
Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol (1992) 1.13
Prevention of immune precipitation by purified classical pathway complement components. Clin Exp Immunol (1984) 1.09
N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J Exp Med (1995) 1.05
Study on C3-like factor in the serum of a C3-deficient subject. Immunology (1984) 0.98
Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading. J Exp Med (1981) 0.96
C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3. Immunology (1984) 0.89
The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase. Biochem J (1981) 0.87
Cooperative interaction of factor B and other complement components with mononuclear cells in the antibody-independent lysis of xenogeneic erythrocytes. J Exp Med (1982) 0.84
A low molecular weight inhibitor of the alternative complement pathway. I. Its isolation from human urine and the reaction mechanism. Immunology (1980) 0.84
The chemical mediation of delayed hypersensitivity skin reactions: III. Purification and characterization of a precursor protein for macrophage-chemotactic factor in normal guinea pig plasma. Am J Pathol (1982) 0.84
The complement component C5 of the common carp (Cyprinus carpio): cDNA cloning of two distinct isotypes that differ in a functional site. Immunogenetics (2003) 0.80
C3-independent immune haemolysis: mechanism of membrane attack complex formation. Immunology (1986) 0.79
Effect on the human complement system of the major non-steroidal anti-inflammatory drugs: aspirin, indomethacin, phenylbutazone, oxyphenbutazone and sulindac. Clin Exp Immunol (1983) 0.79
The expression of Fc and complement receptors in young, adult and aged mice. Immunology (1985) 0.78
The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system. Immunology (1986) 0.78
Novel Mutations Causing C5 Deficiency in Three North-African Families. J Clin Immunol (2016) 0.77
Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects. Immunology (1989) 0.77
Molecular and expression analysis of complement component C5 in the nurse shark (Ginglymostoma cirratum) and its predicted functional role. Fish Shellfish Immunol (2009) 0.76
Third component of human complement: purification from plasma and physicochemical characterization. Biochemistry (1976) 7.80
Large scale isolation of functionally active components of the human complement system. J Biol Chem (1981) 5.26
IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity (1998) 4.65
Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol (1997) 4.22
Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A (1998) 3.85
Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol (1993) 3.29
Tritium labeling of proteins to high specific radioactivity by reduction methylation. J Biol Chem (1980) 3.04
Evidence for presence of an internal thiolester bond in third component of human complement. Proc Natl Acad Sci U S A (1980) 3.00
Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol (2000) 2.55
The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats. Cell (1986) 2.36
Primitive deuterostomes from the Chengjiang Lagerstätte (Lower Cambrian, China). Nature (2001) 2.31
Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24
Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J Exp Med (1994) 2.22
Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun (1999) 2.19
Discovery of new human beta-defensins using a genomics-based approach. Gene (2001) 2.08
Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol (1996) 2.06
Metabolism of gallic acid and syringic acid by Pseudomonas putida. J Biol Chem (1972) 2.04
Purification and properties of 4-hydroxy-4-methyl-2-oxoglutarate aldolase. J Biol Chem (1972) 2.04
Stat6 regulation of in vivo IL-4 responses. J Immunol (2000) 1.97
Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes. J Exp Med (1977) 1.79
An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J Exp Med (1991) 1.75
Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100. Proc Natl Acad Sci U S A (1985) 1.72
Development of an assay to measure in vivo cytokine production in the mouse. Int Immunol (1999) 1.68
Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Natl Acad Sci U S A (1987) 1.68
Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation. Biochemistry (1980) 1.67
Structural studies of human gamma D myeloma protein. Biochemistry (1970) 1.66
The role of IL-4 in Heligmosomoides polygyrus-induced alterations in murine intestinal epithelial cell function. J Immunol (2001) 1.56
Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer. J Immunol (1981) 1.55
Structural analysis of human complement protein H: homology with C4b binding protein, beta 2-glycoprotein I, and the Ba fragment of B2. J Immunol (1986) 1.53
Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism. J Immunol (2000) 1.52
Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol (2001) 1.52
Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry (1985) 1.49
Enzymic degradation of the Fc fragment of rabbit immunoglobulin IgG. Biochem J (1967) 1.49
Temporal and spatial relations between age specific mortality and ambient air quality in the United States: regression results for counties, 1960-97. Occup Environ Med (2002) 1.47
Third component of human complement: structural analysis of the polypeptide chains of C3 and C3b. Biochemistry (1979) 1.44
Third component of human complement: structural requirements for its function. Biochemistry (1980) 1.38
Murine protein H is comprised of 20 repeating units, 61 amino acids in length. Proc Natl Acad Sci U S A (1986) 1.37
Nucleotide sequence of complementary DNA and derived amino acid sequence of murine complement protein C3. Philos Trans R Soc Lond B Biol Sci (1984) 1.29
Evaluation of a food frequency questionnaire-food composition approach for estimating dietary intake of inorganic arsenic and methylmercury. Cancer Epidemiol Biomarkers Prev (1997) 1.29
Primary structure of bovine calpactin I heavy chain (p36), a major cellular substrate for retroviral protein-tyrosine kinases: homology with the human phospholipase A2 inhibitor lipocortin. Biochemistry (1986) 1.28
Orientation and dynamics of an antimicrobial peptide in the lipid bilayer by solid-state NMR spectroscopy. Biophys J (2001) 1.27
The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob Agents Chemother (2001) 1.22
Third component of human complement: localization of the internal thiolester bond. Proc Natl Acad Sci U S A (1982) 1.20
Sequence determination of the thiolester site of the fourth component of human complement. Proc Natl Acad Sci U S A (1981) 1.19
The beta-Cys-gamma-Glu thiolester bond in human C3, C4, and alpha 2-macroglobulin. Springer Semin Immunopathol (1983) 1.18
CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J Exp Med (1994) 1.17
Binding of C3b proceeds by a transesterification reaction at the thiolester site. Nature (1982) 1.17
Fourth component of human complement: studies of an amine-sensitive site comprised of a thiol component. Biochemistry (1981) 1.17
Primary structure of the fifth component of murine complement. Biochemistry (1987) 1.16
Genome size in conodonts (chordata): inferred variations during 270 million years. Science (1988) 1.15
A novel murine beta -defensin expressed in tongue, esophagus, and trachea. J Biol Chem (2000) 1.14
Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells. Antimicrob Agents Chemother (2001) 1.14
Burgess shale faunas and the cambrian explosion. Science (1989) 1.13
Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother (2001) 1.10
IL-13-mediated worm expulsion is B7 independent and IFN-gamma sensitive. J Immunol (2000) 1.07
Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J Exp Med (1995) 1.07
Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob Agents Chemother (2001) 1.06
Restricted structural heterogeneity in antibodies: might different heavy chains have a common light chain? Nat New Biol (1972) 1.05
NH2-terminal structure and cleavage of guinea pig pro-C3, the precursor of the third complement component. J Biol Chem (1981) 1.05
The superfamily of C3b/C4b-binding proteins. Fed Proc (1987) 1.04
Structure of murine complement component C3. I. Nucleotide sequence of cloned complementary and genomic DNA coding for the beta chain. J Biol Chem (1984) 1.02
Structure of murine complement component C3. II. Nucleotide sequence of cloned complementary DNA coding for the alpha chain. J Biol Chem (1984) 1.01
cDNA structure of murine C4b-binding protein, a regulatory component of the serum complement system. Biochemistry (1987) 1.01
N- and C-terminal sequences of a heavy chain disease protein and its genetic implications. Nature (1967) 1.00
ATPase center of bacteriophage lambda terminase involved in post-cleavage stages of DNA packaging: identification of ATP-interactive amino acids. J Mol Biol (2000) 0.99
Chromosomal location of the genes encoding complement components C5 and factor H in the mouse. J Immunol (1986) 0.97
Daily mortality in the Philadelphia metropolitan area and size-classified particulate matter. J Air Waste Manag Assoc (2000) 0.97
cDNA sequence and tissue distribution of the mRNA for bovine and murine p11, the S100-related light chain of the protein-tyrosine kinase substrate p36 (calpactin I). J Biol Chem (1987) 0.96
Isolation and sequence analysis of a cDNA clone encoding the fifth complement component. J Biol Chem (1985) 0.96
The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency. J Exp Med (1987) 0.96
The molecular determinants of the A11 and A12 allotypic specificities in rabbit immunoglobulin. Biochemistry (1969) 0.96
The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment. Biochemistry (2001) 0.95
Mapping of a retinoic acid-responsive element in the promoter region of the complement factor H gene. J Biol Chem (1990) 0.95
CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J Immunol (1997) 0.94
Factor H. Curr Top Microbiol Immunol (1990) 0.94
New burgess shale fossil sites reveal middle cambrian faunal complex. Science (1983) 0.93
Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol Immunol (2003) 0.92
Molecular cloning and characterization of rat genes encoding homologues of human beta-defensins. Infect Immun (1999) 0.92
Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response. J Immunol (1997) 0.92
Abundant human beta-defensin-1 expression in milk and mammary gland epithelium. J Pediatr (2001) 0.92
Rapid stimulation of large specific antibody responses with conjugates of antigen and anti-IgD antibody. J Immunol (1990) 0.91
Diverse expression of group a allotype specificities on the heavy chains of homogeneous rabbit antibodies. J Exp Med (1973) 0.91
Antigen presentation by B lymphocytes to CD4+ T lymphocytes in vivo: importance for B lymphocyte and T lymphocyte activation. Semin Immunol (1992) 0.91
Genetic organization of complement receptor-related genes in the mouse. J Exp Med (1989) 0.90
Identification and sequence analysis of four complement factor H-related transcripts in mouse liver. J Biol Chem (1990) 0.90
IL-4 promotes the migration of circulating B cells to the spleen and increases splenic B cell survival. J Immunol (2000) 0.89
Carboxy-terminal structure of the chain of human IgA myeloma proteins. Biochemistry (1971) 0.88
H. polygyrus: B7-independence of the secondary type 2 response. Exp Parasitol (1996) 0.88
Structure of the murine complement factor H gene. J Biol Chem (1988) 0.88
Molecular analysis of human complement component C5: localization of the structural gene to chromosome 9. Biochemistry (1988) 0.87
Structural features of the human C3 gene: intron/exon organization, transcriptional start site, and promoter region sequence. Biochemistry (1991) 0.87
Genetic control of rabbit H chain biosynthesis. Ann N Y Acad Sci (1971) 0.87
Structure and chromosome assignment of the murine p36 (calpactin I heavy chain) gene. Biochemistry (1990) 0.86
Lophophorate phylogeny. Science (1996) 0.86